Independent investing research and personal finance for IrelandUnderstand. Decide. Compound.

Health3 min read

How does Mounjaro work? Tirzepatide and the science of GIP and GLP-1

Mounjaro contains tirzepatide. Learn how one molecule activates two hormone receptors, what this changes in the body and what to ask a prescriber.

Mounjaro KwikPen containing tirzepatideHealth / The Compound journal

Photo: Raimond Spekking · Wikimedia Commons · CC BY-SA 4.0 · cropped · Illustrative image.

Mounjaro contains tirzepatide, a medicine that activates two hormone receptors called GIP and GLP-1. It is given by weekly injection. Its EU authorisation covers type 2 diabetes and weight management in eligible adults, with criteria and prescribing instructions set out in the product information. EMA Mounjaro overview · EMA product information

The Science Behind the Drug

GIP stands for glucose-dependent insulinotropic polypeptide. GLP-1 stands for glucagon-like peptide-1. Both are hormones released by the gut in response to food. They are called incretins because they help the body release insulin when glucose is elevated. Tirzepatide is a single molecule that activates the receptors for both hormones. EMA product information, section 5.1

Activation of these receptors affects insulin release and blood glucose. Tirzepatide also reduces appetite and food intake. The receptors are found in areas of the brain involved in appetite regulation, among other tissues. Clinical trials test the effects of the whole medicine, so the diagram shows its targets rather than how much each receptor contributes to the overall result. EMA product information, section 5.1

Semaglutide activates the GLP-1 receptor. Tirzepatide activates the GLP-1 receptor and the GIP receptor.
Receptor targets for semaglutide and tirzepatide. The diagram shows which targets each medicine activates. EMA prescribing information.

How does tirzepatide compare with semaglutide?

Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on GLP-1 and GIP receptors. That distinction explains why tirzepatide is described as a dual GIP and GLP-1 receptor agonist. To compare clinical outcomes, look at studies that specify the dose, population and outcome measured. EMA: Mounjaro · EMA: Wegovy

What should you discuss with your prescriber?

Nausea, diarrhoea and vomiting can occur. Severe, persistent abdominal pain needs urgent medical advice as it can be a sign of pancreatitis. Tell your prescriber if you use insulin or a sulfonylurea, have significant digestive symptoms, or are pregnant or planning a pregnancy. Tell your procedure team if you are due to receive general anaesthesia or deep sedation. EMA Mounjaro product information and leaflet

What two receptor targets can and cannot tell you

GIP and GLP-1 are signals released after food intake. Tirzepatide can activate both receptors. That makes its mechanism different from semaglutide’s, but receptor counts cannot predict how much weight any person will lose or how they will tolerate treatment. Outcomes have to be read from studies in the relevant population. A study in type 2 diabetes and a weight-management study may measure different outcomes and use different background treatment. EMA Mounjaro information

Which information helps when a prescriber is reviewing you?

Bring why it was started, the exact product, any changes to the prescription and the timing of appetite or gastrointestinal symptoms. If you take insulin or another drug that can lower glucose, ask how the treatment plan deals with low readings. Tell the team about persistent vomiting or difficulty drinking, and about upcoming procedures involving deep sedation or anaesthesia. Severe persistent abdominal pain warrants urgent assessment. EMA Mounjaro information

If comparing with another product or changing treatment, check whether the plan refers to semaglutide or liraglutide. These products have their own formulations, schedules and review points.

Read more on Compound Health

Cover photograph and cropped versions licensed under CC BY-SA 4.0.

YOUR PRIVACY

Help us understand what gets read.

With your permission, anonymous Google Analytics measurements tell us which articles are useful. We do not send calculator entries or form values. You can decline and still read everything.